Explore Capital Management LLC Has $10.21 Million Stock Position in Tenet Healthcare Corporation $THC

Explore Capital Management LLC trimmed its position in Tenet Healthcare Corporation (NYSE:THC) by 18.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,300 shares of the company’s stock after selling 11,200 shares during the quarter. Tenet Healthcare accounts for 6.3% of Explore Capital Management LLC’s holdings, making the stock its 7th largest holding. Explore Capital Management LLC owned 0.06% of Tenet Healthcare worth $10,213,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of THC. William B. Walkup & Associates Inc. acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth $32,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the second quarter valued at about $35,000. Westside Investment Management Inc. lifted its holdings in shares of Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares during the last quarter. Trust Co. of Vermont acquired a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $41,000. Finally, Caitong International Asset Management Co. Ltd increased its position in Tenet Healthcare by 2,227.3% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after purchasing an additional 245 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analysts Set New Price Targets

THC has been the topic of a number of research reports. Jefferies Financial Group boosted their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Cantor Fitzgerald boosted their price objective on Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. Royal Bank Of Canada increased their target price on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research report on Thursday, February 12th. JPMorgan Chase & Co. upped their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Finally, Truist Financial lifted their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Stock Performance

NYSE:THC opened at $229.56 on Friday. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $235.77. The company has a 50 day simple moving average of $201.87 and a two-hundred day simple moving average of $197.42. The company has a market capitalization of $19.96 billion, a PE ratio of 14.82, a P/E/G ratio of 1.13 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the firm posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at $5,623,945.60. The trade was a 7.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.